In this study, compared with doxorubicin, dual inhibition of H3K9me2 and H3K27me3 with the G9a inhibitor, UNC0642, and the EZH2 inhibitor, UNC1999, promoted tumor cell senescencewithout triggering SASP (Figure 3). This evidence concerns the gene EHMT2 and neoplasm.